BP002447-CYT-429: Recombinant Human B-cell Activating Factor Receptor (BAFF R) Protein
Source: E. coli-derived.
Determined by its ability to block BAFF induced mouse splenocyte survival. The expected ED50 for this effect is 1000-5000 ng/ml corresponding to a Specific Activity of 200-1000IU/mg in the presence of 1.0 ug/ml of human soluble BAFF.
Purity: > 95% by RP-HPLC and SDS-PAGE.